Latest Articles
-
Will Medtronic Stock See Higher Levels Post Q2 Results?
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2023 second-quarter results on Tuesday, November 22. We expect Medtronic to post revenues and earnings in line with the street estimates. The company should benefit from its new products and...
-
Medtronic Stock Is A Better Pick Over This Pharmaceuticals Bellwether
We believe Medtronic stock (NYSE: MDT) is currently a better pick than Johnson & Johnson stock (NYSE: JNJ), given its better prospects. Although Medtronic is trading at a comparatively lower valuation of 3.5x trailing revenues vs. 4.5x ...
-
Should You Buy Medtronic Stock Around $90?
Medtronic stock (NYSE: MDT) reported its Q1FY23 results on Aug 23, with revenue falling above and earnings below our estimates. MDT stock has declined 6% in a week, while it’s down 3% in a month. After the recent fall, we believe MDT stock is ...
-
What To Expect From Medtronic’s Q1?
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2023 first-quarter results on Tuesday, August 23. We expect Medtronic to post revenues and earnings above the street estimates, aided by its newly launched cardiovascular products. However, ...
-
Will Medtronic Stock See Higher Levels?
Medtronic stock (NYSE: MDT) has fallen 9% in a month, underperforming the broader markets, with the S&P500 rising 3%. The company recently reported its Q4 FY22 results, which fell short of expectations. Medtronic’s revenue of $8.1 bil...
-
Will Medtronic Stock See Higher Levels Following Its Q4 Results?
Medtronic (NYSE: MDT) is scheduled to report its fiscal fourth-quarter results on Thursday, May 26. We expect Medtronic to post revenues and earnings slightly above the consensus estimate. The company should benefit from a continued uptick in pro...
-
Here’s What Makes Medtronic Stock A Better Pick Over This Pharmaceuticals Company
We think that Medtronic stock (NYSE: MDT) is currently a better pick than Eli Lilly stock (NYSE: LLY), given Medtronic’s better prospects and comparatively lower valuation. MDT stock trades at a P/S ratio of 4.4x, compared to 9.7x for L...
-
Is There A Better Pick Over Medtronic Stock?
We think that CVS Health stock (NYSE: CVS) is currently a better pick than Medtronic stock (NYSE: MDT), given CVS’s better prospects and comparatively lower valuation. CVS stock trades at a P/S ratio of 0.4x, compared to 4.4x for MDT st...
-
This Medical Devices Company Is Likely To Offer Better Returns Over Medtronic Stock
We think that Stryker Corp. stock (NYSE: SYK) currently is a better pick compared to its industry peer, Medtronic stock (NYSE: MDT), despite it being the more expensive of the two, trading at 5.7x trailing revenues compared to 4.7x for Medtr...
-
Company Of The Day: Medtronic
What? Medtronic (NYSE:MDT) posted a mixed set of Q3 FY’22 results. While revenues missed expectations, remaining roughly flat year-over-year at $7.8 billion, adjusted EPS was in-line with estimates at $1.37. Guidance for Q4 was also in-li...
-
What To Expect From Medtronic’s Q3?
[Updated: Feb 17, 2022] Medtronic Q3FY22 Earnings Preview Medtronic stock (NYSE: MDT) is scheduled to report its fiscal third-quarter results on Tuesday, Feb 22. We expect Medtronic to post revenues and earnings above the consensus estimates. T...
-
Should You Buy Boston Scientific Stock Over Its Industry Peer?
We think that Boston Scientific stock (NYSE: BSX) currently is a better pick compared to its industry peer, Medtronic stock (NYSE: MDT), despite it being the more expensive of the two, trading at 5.3x trailing revenues compared to 4.4x for M...
-
What’s Happening With Medtronic Stock?
[Updated: Jan 6, 2022] Medtronic Stock Update The stock price of Medtronic has seen a fall of 4% over the last month, underperforming the broader indices, with the S&P 500 rising 2% over the same period. This underperformance can largely be ...
-
What’s Next For Medtronic Stock After A Mixed Q2?
[Updated: Nov 26, 2021] Medtronic Earnings Update Medtronic (NYSE:MDT) recently reported its Q2 FY22 results, which were mixed with revenue slightly below, and earnings above our estimates. The company reported sales of around $7.8 billion (up ...
-
What To Expect From Medtronic’s Q2?
Medtronic stock (NYSE: MDT) is scheduled to report its fiscal second-quarter results on Tuesday, Nov 23. We expect Medtronic to likely post revenues and earnings largely in-line with the consensus estimates. The company is likely to benefit from ...
